This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Gent Universiteit, University of Ghent. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Zottegem, BE (2006)
- Brakel, BE (2011)
Company Filing History:
Years Active: 2006-2011
Title: Karolien De Bosscher: Innovator in Anti-Inflammatory Compounds
Introduction
Karolien De Bosscher is a notable inventor based in Brakel, Belgium. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 2 patents, her work is recognized for its potential impact on treating inflammatory diseases.
Latest Patents
Her latest patents include innovative compounds such as synephrine derivatives that are useful as anti-inflammatory agents. This invention provides compounds having a specific structural formula aimed at reducing inflammation. Another significant patent involves the use of carboxy compounds, specifically 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride, in the treatment of inflammatory diseases. This patent also includes a pharmaceutical composition that combines this active ingredient with acceptable excipients, enhancing its therapeutic potential.
Career Highlights
Karolien has worked at prestigious institutions, including Universiteit Gent and Gent Universiteit. Her research and development efforts have positioned her as a key figure in her field, contributing to advancements in pharmaceutical sciences.
Collaborations
Throughout her career, Karolien has collaborated with esteemed colleagues such as Wim Vanden Berghe and Guy Haegeman. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Karolien De Bosscher's contributions to the field of anti-inflammatory agents highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving treatment options for inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile